BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6140517)

  • 1. Resistant Shigella dysenteriae.
    Panhotra BR; Desai B
    Lancet; 1983 Dec; 2(8364):1420. PubMed ID: 6140517
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasmid-mediated resistance to nalidixic acid in Shigella dysenteriae type 1.
    Munshi MH; Sack DA; Haider K; Ahmed ZU; Rahaman MM; Morshed MG
    Lancet; 1987 Aug; 2(8556):419-21. PubMed ID: 2887725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nalidixic-acid-resistant Shigella dysenteriae I.
    Panhotra BR; Desai B; Sharma PL
    Lancet; 1985 Mar; 1(8431):763. PubMed ID: 2858035
    [No Abstract]   [Full Text] [Related]  

  • 4. Nalidixic acid-resistant Shigella dysenteriae type I in KwaZulu-Natal.
    Karas JA; Pillay DG
    S Afr Med J; 1996 Jan; 86(1):93. PubMed ID: 8685796
    [No Abstract]   [Full Text] [Related]  

  • 5. Emergence of nalidixic acid resistant Shigella dysenteriae type 1 in Thailand: an outbreak associated with consumption of a coconut milk dessert.
    Hoge CW; Bodhidatta L; Tungtaem C; Echeverria P
    Int J Epidemiol; 1995 Dec; 24(6):1228-32. PubMed ID: 8824867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple drug-resistant Shigella dysenteriae type 1 in Rajbari district, Bangladesh.
    Jahan Y; Hossain A
    J Diarrhoeal Dis Res; 1997 Mar; 15(1):17-20. PubMed ID: 9308296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nalidixic-acid resistant Shigella dysenteriae type 1 in eastern India.
    Sen D; Dutta P; Deb BC; Pal SC
    Lancet; 1988 Oct; 2(8616):911. PubMed ID: 2902361
    [No Abstract]   [Full Text] [Related]  

  • 8. Mutator plasmid in a nalidixic acid-resistant strain of Shigella dysenteriae type 1.
    Ambler JE; Drabu YJ; Blakemore PH; Pinney RJ
    J Antimicrob Chemother; 1993 Jun; 31(6):831-9. PubMed ID: 8360123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nalidixic acid in Shigella dysenteriae outbreaks.
    Malengreau M
    Lancet; 1984 Jul; 2(8395):172. PubMed ID: 6146074
    [No Abstract]   [Full Text] [Related]  

  • 10. Mechanisms of quinolone resistance in clinical isolates of Shigella dysenteriae.
    Ahamed J; Gangopadhyay J; Kundu M; Sinha AK
    Antimicrob Agents Chemother; 1999 Sep; 43(9):2333-4. PubMed ID: 10577351
    [No Abstract]   [Full Text] [Related]  

  • 11. [On the transmission of antibiotic resistance by the conjugation method. II. The effect of forazolidon and levomycetin on the episomic transmission of antibiotic resistance in some bacteria of the intestinal group].
    Sherishorina SI; Shenderov BA
    Zh Mikrobiol Epidemiol Immunobiol; 1968; 45(10):90-4. PubMed ID: 4893996
    [No Abstract]   [Full Text] [Related]  

  • 12. Shigellosis in Bangladesh: a reply.
    Shahid NS; Haider K; Sack DA; Rahaman MM
    J Infect Dis; 1987 Sep; 156(3):535. PubMed ID: 3302055
    [No Abstract]   [Full Text] [Related]  

  • 13. Fluoroquinolone-resistant Shigella dysenteriae type 1 in northeastern Bangladesh.
    Naheed A; Kalluri P; Talukder KA; Faruque AS; Khatun F; Nair GB; Mintz ED; Breiman RF
    Lancet Infect Dis; 2004 Oct; 4(10):607-8. PubMed ID: 15451486
    [No Abstract]   [Full Text] [Related]  

  • 14. Antimicrobial resistance of Shigellae isolated in Michigan.
    Gordon RC; Thompson TR; Carlson W; Dyke JW; Stevens LI
    JAMA; 1975 Mar; 231(11):1159-61. PubMed ID: 1089819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmid characterization of drug-resistant Shigella dysenteriae 1 from an epidemic in Central Africa.
    Frost JA; Willshaw GA; Barclay EA; Rowe B; Lemmens P; Vandepitte J
    J Hyg (Lond); 1985 Apr; 94(2):163-72. PubMed ID: 3886782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiresistant Shigella infections in Bangladesh.
    Bennish M; Eusof A; Kay B; Wierzba T
    Lancet; 1985 Aug; 2(8452):441. PubMed ID: 2863461
    [No Abstract]   [Full Text] [Related]  

  • 17. Antimicrobial resistance of Shigella isolates in Bangladesh, 1983-1990: increasing frequency of strains multiply resistant to ampicillin, trimethoprim-sulfamethoxazole, and nalidixic acid.
    Bennish ML; Salam MA; Hossain MA; Myaux J; Khan EH; Chakraborty J; Henry F; Ronsmans C
    Clin Infect Dis; 1992 May; 14(5):1055-60. PubMed ID: 1600006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laboratory surveillance of Shigella dysenteriae type 1 in KwaZulu-Natal.
    Karas JA; Pillay DG; Naicker T; Sturm AW
    S Afr Med J; 1999 Jan; 89(1):59-63. PubMed ID: 10070415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiply drug-resistant Shigella dysenteriae type 1 and travelers' diarrhea.
    Bhattacharya SK; Sen D; Nair GB; Bhattacharya MK; Datta P; Datta D
    J Infect Dis; 1986 Oct; 154(4):729-30. PubMed ID: 3528325
    [No Abstract]   [Full Text] [Related]  

  • 20. Changing patterns of serotypes and antimicrobial susceptibilities of Shigella species isolated from children in Calcutta, India.
    Niyogi SK; Mitra U; Dutta P
    Jpn J Infect Dis; 2001 Jun; 54(3):121-2. PubMed ID: 11544405
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.